NeuroBo Pharmaceuticals Gross Margin 1970-1969 | MTVA
Current and historical gross margin for NeuroBo Pharmaceuticals (MTVA) over the last 10 years. The current gross profit margin for NeuroBo Pharmaceuticals as of December 31, 1969 is %.
| NeuroBo Pharmaceuticals Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.022B |
$0.000B |
|
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
|
